Amanote Research
Register
Sign In
Capivasertib Active Against AKT1-Mutated Cancers
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2018-153
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 14, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Generation of a Selectively Cytotoxic Fusion Protein Against P53 Mutated Cancers
BMC Cancer
Cancer Research
Oncology
Genetics
MCC (Mutated in Colorectal Cancers)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
ARID1A-mutated Ovarian Cancers Depend on HDAC6 Activity
Nature Cell Biology
Cell Biology
ZW25 Active in HER2-positive Cancers
Cancer Discovery
Oncology
Clinicopathological Significance of Ataxia Telangiectasia-Mutated (ATM) Kinase and Ataxia Telangiectasia-Mutated and Rad3-Related (ATR) Kinase in MYC Overexpressed Breast Cancers
Breast Cancer Research and Treatment
Cancer Research
Oncology
Vaccination Protects Against Invasive HPV-associated Cancers
International Journal of Cancer
Cancer Research
Oncology
53BP1 Loss Rescues BRCA1 Deficiency and Is Associated With Triple-Negative and BRCA-mutated Breast Cancers
Nature Structural and Molecular Biology
Structural Biology
Molecular Biology
High-Concentration Hydrogen Protects Mouse Heart Against Ischemia/Reperfusion Injury Through Activation of thePI3K/Akt1 Pathway
Scientific Reports
Multidisciplinary
Discovery and Analysis of Consistent Active Sub-Networks in Cancers
BMC Bioinformatics
Biochemistry
Applied Mathematics
Computer Science Applications
Structural Biology
Molecular Biology
